アブストラクト | AIM: Serotonin-norepinephrine reuptake inhibitors (SNRIs) have been extensively utilized for the treatment of depression and anxiety disorders. Clinical trials and real-world data suggest that SNRIs may cause reproductive toxicity. To comprehensively assess this association, we conducted a pharmacovigilance study. METHODS: We utilized various disproportionality analysis algorithms, including reporting odds ratio (ROR), proportional reporting ratio (PRR), bayesian confidence propagation neural network (BCPNN), and multi-item gamma poisson shrinker (MGPS), to assess the significance of reproductive toxicity-related adverse events (AEs) reported to FDA Adverse Event Reporting System (FAERS) from January 2004 to December 2023, with subgroup analysis conducted by sex and age. RESULTS: Duloxetine and venlafaxine were associated with 14 and 25 AE signals related to reproductive toxicity, respectively, with erectile dysfunction (ED) and retrograde ejaculation identified as shared important medical events (IMEs). ED had the highest reporting frequency, strongest in venlafaxine-treated patients under 45 years (ROR 4.34, PRR 4.33, IC 2.09, EBGM 4.25). Retrograde ejaculation was newly identified. With decreasing incidence, venlafaxine's median ED onset was 122.5 days and duloxetine's 38 days. CONCLUSION: Our study provides evidence through an extensive analysis of the large-scale real-world FAERS database, aiding healthcare professionals in mitigating, and prioritizing SNRI-related reproductive toxicity AEs. |
ジャーナル名 | CNS neuroscience & therapeutics |
Pubmed追加日 | 2024/12/13 |
投稿者 | Xi, Yujia; Bao, Zhuocheng; Guo, Qiang; Wang, Jingqi; Jing, Zhinan; Di, Jingkai; Yang, Ke |
組織名 | Department of Urology, Second Hospital of Shanxi Medical University, Taiyuan,;China.;Male Reproductive Medicine Center, Shanxi Medical University, Jinzhong, China.;Department of Orthopedics, Second Hospital of Shanxi Medical University, Taiyuan, |
Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/39670536/ |